1Coley WB. II. Contribution to the knowledge of sarcoma. Ann Surg, 1891,14: 199-220.
2Clauberg KW. The immunobiological legacy of Emil von Behring and Paul Ehrlich. Dtsch Med J, 1954,5:138-146.[in undetermined language].
3Burnet M. Cancer; a biological approach. I. The processes of control. Br Med J, 1957,1 :779-786.
4Thomas L, Lawrence HS. Cellular and humoral aspects of the hypersensitive states. New York: Hoeber-Harper, 1959:529-532.
5Knuth A, Wolfel T, Klehmann E, et al. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA, 1989,86:2804-2808.
6Parker GA, Rosenberg SA. Serologic identification of multiple tumor-associated antigens on murine sarcomas. J Natl Cancer Inst, 1977,58:1303-1309.
7Cheever MA, Allison JP, Ferris AS, et al. The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research. Clin Cancer Res, 2009,15:5323-5337.
8Nukaya I, Yasumoto M, Iwasaki T, et al. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor?reactive cytotoxic T lymphocyte. Int J Cancer, 1999,80:92-97.
9Rosenberg SA, Kawakami Y, Robbins PF, et al. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv Cancer Res, 1996,70: 145-177.
10Wayteck L; Breckpot K, Demeester J, et al. A personalized view on cancer immunotherapy. Cancer Lett, 2014,352: 113-125.
6APTSIAURI N,GARCIA-LORA A M,CABRERA T.Potential Therapeutic Approaches for Increasing Tumor Immunogenicity by Upregulation of Tumor HLA Class I Expression MHC Class I Antigens In Malignant Cells[J].Springer New York,2013,8(6):47-50.
7TANAKA K,TSUCHIKAWA T,MIYAMOTO M,et al.Down- regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients[J].J Clin Oncol,2012,40(4):965.
8BOBBIE S,GOSTOUT M,CALHOUN ES,et al.TAPI,TAP2,and HLA-DR2 alleles are predictors of cervical cancer risk[J].Gynecologic Oncology,2003,88(2):326-332.
9CRESSWELL AC,SISLEY K.Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with pro- gression to metastatic disease[J].Me lanoma Res,2001,11(3);275-281.
10CROMME FV,AIREY J,HEEMELS MT,et al.Loss of Trans- porter,Encoded by the TAP-I Gene,Is Highl y Correlated with Loss of HLA Expression in Cervical Carcinomas[J].J Exp Med,1994,179(1):335-340.
